Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Pain, Postoperative 1Inflammatory Bowel Diseases 1Immune System Suppression 1Diverticulitis 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Breakthrough Pain 1

Interventions

Morphine 1Dexmedetomidine 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Immune System Suppression × Morphine × Clear all
NCT03024957 2021-01-14

Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity

Assiut University

Phase 1/2 Unknown
30 enrolled

Immune System Suppression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡